Mark Bagarazzi is Chief Medical Officer at INOVIO PHARMACEUTICALS, INC. (INO). They have made 1 open-market trade across 1 company since 2013, most recently 2019-03-05.
CIK 0001539067
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $34K since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INO | 109,080 | $108K |
Shares reported on the most recent Form 4, priced at the 2019-03-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INO | BUY | 2013-04-16 | 2013-04-16 | $0.56 | $34K | -20.0% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.